Does DURVALUMAB Cause Pleural effusion? 212 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 212 reports of Pleural effusion have been filed in association with DURVALUMAB (IMFINZI). This represents 1.2% of all adverse event reports for DURVALUMAB.
212
Reports of Pleural effusion with DURVALUMAB
1.2%
of all DURVALUMAB reports
46
Deaths
131
Hospitalizations
How Dangerous Is Pleural effusion From DURVALUMAB?
Of the 212 reports, 46 (21.7%) resulted in death, 131 (61.8%) required hospitalization, and 17 (8.0%) were considered life-threatening.
Is Pleural effusion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DURVALUMAB. However, 212 reports have been filed with the FAERS database.
What Other Side Effects Does DURVALUMAB Cause?
Death (2,817)
Malignant neoplasm progression (1,330)
Pneumonitis (827)
Radiation pneumonitis (786)
Pyrexia (573)
Diarrhoea (530)
Pneumonia (453)
Dyspnoea (444)
Interstitial lung disease (430)
Off label use (395)
What Other Drugs Cause Pleural effusion?
DASATINIB (2,424)
METHOTREXATE (1,310)
CYCLOPHOSPHAMIDE (1,239)
IBRUTINIB (1,205)
RITUXIMAB (1,168)
PREDNISONE (1,144)
NIVOLUMAB (1,061)
ADALIMUMAB (1,036)
DEXAMETHASONE (879)
PACLITAXEL (862)
Which DURVALUMAB Alternatives Have Lower Pleural effusion Risk?
DURVALUMAB vs DUTASTERIDE
DURVALUMAB vs DUTASTERIDE\TAMSULOSIN
DURVALUMAB vs DUVELISIB
DURVALUMAB vs DYDROGESTERONE
DURVALUMAB vs EBASTINE